Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Remdesivir Approved by FDA Experimental Antiviral Oct/15/2020 Oct/23/2020 0
Digitoxin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/24/2020 Oct/17/2020 0
Raloxifene HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020 Oct/17/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Sep/14/2020 Oct/05/2020 0
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/08/2020 Oct/04/2020 0
Conivaptan HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/24/2020 Sep/18/2020 0
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/11/2020 Aug/25/2020 0
Clofazimine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/24/2020 Jul/28/2020 0